Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhuan-Zhuan Mu"'
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 108:1330-1337
Context Using response to surgery when tailoring radioiodine (RAI) therapy for papillary thyroid cancer (PTC) is valued but lacks prospective validation. Objective To spare RAI thyroid remnant ablation among patients with intermediate-risk PTCs using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b19219dc17c809ca00762d67325e54
https://doi.org/10.1210/clinem/dgac745
https://doi.org/10.1210/clinem/dgac745
Publikováno v:
Endocrine Practice. 28:265-270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bca06b541c67ac616f02ed73027df4bb
https://doi.org/10.1016/j.eprac.2021.12.005
https://doi.org/10.1016/j.eprac.2021.12.005
Publikováno v:
Journal of Clinical Endocrinology & Metabolism; Jun2023, Vol. 108 Issue 6, p1330-1337, 8p
Autor:
Yan-Song Lin, Hui Yang, Xiao-Yi Li, Li-Qing Wu, Jin-Guo Xu, Ai-Min Yang, Zai-Rong Gao, Yong Ding, Ying-Qiang Zhang, Kai Chen, Zhuan-Zhuan Mu, Jian-Min Jia, Na Niu, Di Sun, Xin Zhang, Shao-Qiang Zhang, Qian-Qian Geng, Ya-Jing Zhang, Fang-Ni Chen, Bao-Xia He
Publikováno v:
European journal of nuclear medicine and molecular imaging. 49(12)
Purpose Thyroid hormone withdrawal (THW) inevitably induced hypothyroidism in patients with differentiated thyroid cancer (DTC), we aimed to evaluate the safety and efficacy of a novel recombinant human thyroid-stimulating hormone (rhTSH, ZGrhTSH) as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::409826b09f53b1cf38b792c0b42aa213
https://pubmed.ncbi.nlm.nih.gov/35781600
https://pubmed.ncbi.nlm.nih.gov/35781600
Publikováno v:
Chonnam Medical Journal. 2019, Vol. 55 Issue 3, p127-135. 9p.
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 28(3)
To assess the impact of serine/threonine-protein kinase B-Raf (BRAF) V600E and telomerase reverse transcriptase (TERT) promoter mutations in patients with distant-metastatic differentiated thyroid cancer (DM-DTC) based on thyroglobulin (Tg) response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b817ff5f9edfc0efa4f2f43f10b2b7cb
https://pubmed.ncbi.nlm.nih.gov/34890787
https://pubmed.ncbi.nlm.nih.gov/34890787
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fae322415ab2896e7195ade753263a37
https://doi.org/10.2139/ssrn.3970706
https://doi.org/10.2139/ssrn.3970706
Publikováno v:
Chonnam Medical Journal
Most differentiated thyroid cancer (DTC) patients have an excellent prognosis. However, about one-third of DTC patients with recurrent or metastatic disease lose the hallmark of specific iodine uptake initially or gradually and acquire radioactive io
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec758e0ca25b5cb5901a7da28a49cae6
https://pubmed.ncbi.nlm.nih.gov/31598469
https://pubmed.ncbi.nlm.nih.gov/31598469